Stocksigma LogoStocksigma Logo

Titan Biotech Board to Consider Q2 Results on 5th Nov'26

Titan Biotech Limited has scheduled a Board of Directors meeting on 5th Nov'26 to consider and approve the unaudited standalone and consolidated financial

Titan Biotech Board to Consider Q2 Results on 5th Nov'26

Titan Biotech Ltd 路 Intimation 路 05 Nov 2026, 5:30 am

Titan Biotech Board to Consider Q2 Results on 5th Nov'26 Titan Biotech Limited has scheduled a Board of Directors meeting on 5th Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the second quarter and half-year ended 30th Sep'26. In accordance with SEBI insider trading regulations, the trading window for dealing in company securities has been closed since 1st Oct'26 and will reopen 48 hours after the declaration of the board meeting outcomes.

Original exchange filing (PDF)

More announcements from Titan Biotech Ltd

All Titan Biotech Ltd announcements